Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)
NCT01568021
·
clinicaltrials.gov ↗
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Retinal Vein Occlusion
Macular Edema
Interventions
OTHER:
No Intervention
Sponsor
Allergan